Optical coherence tomography (OCT) evaluation after coronary stenting: The "black hole" and other low OCT signal-intensity areas

EuroIntervention

Volumn 7, Issue 12, 2012, Pages 1367-1371

  Landmesser, Ulf ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PROTEOGLYCAN; RAPAMYCIN;

BLACK HOLE PHENOMENON; CARDIOVASCULAR RESPONSE; CLINICAL EVALUATION; CORONARY STENT; DISEASE COURSE; DRUG ELUTING STENT; EDITORIAL; FIBRIN FORMATION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; OPTICAL COHERENCE TOMOGRAPHY; RESTENOSIS; SIGNAL INTENSITY; SIGNAL PROCESSING; THROMBOGENESIS; TISSUE STRUCTURE;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; PACLITAXEL; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84860741735     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I12A215     Document Type: Editorial

References (17)

1. Kay IP, Wardeh AJ, Kozuma K, Sianos G, Regar E, Knook M, van der Giessen WJ, Thury A, Ligthart JM, Coen VM, Levendag PC, Serruys PW. The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation. Eur Heart J. 2001;22:1311-1317. (Pubitemid 32737623)
2. Castagna MT, Mintz GS, Weissman N, Maehara A, Finet G, Waksman R. "Black hole": Echolucent restenotic tissue after brachytherapy. Circulation. 2001;103:778. (Pubitemid 32144210)
3. Kay IP, Ligthart JM, Virmani R, van Beusekom HM, Kozuma K, Carter AJ, Sianos G, van der Giessen WJ, Wardeh AJ, de Feyter PJ, Serruys PW. The black hole: Echolucent tissue observed following intracoronary radiation. Int J Cardiovasc Intervent. 2003;5:137-142. (Pubitemid 37127998)
4. Hirose M, Kobayashi Y, Leon MB. Echolucent neointimal hyperplasia "dark wall" after sirolimus eluting stent implantation. Heart. 2004;90:1143. (Pubitemid 39279898)
5. Costa MA, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Teirstein P, Carter A, Leon MB, Moses J, Zenni M, Yakubov S, Guzman LA, Gilmore P, Macaya C, Bass TA. Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation. Am J Cardiol. 2006;97:203-206. (Pubitemid 43139237)
6. Costa Jde R, Jr., Mintz GS, Carlier SG, Fujii K, Sano K, Kimura M, Tanaka K, Lui J, Moses JW, Leon MB. Frequency and determinants of black holes in sirolimus-eluting stent restenosis. J Invasive Cardiol. 2006;18:348-352 (Pubitemid 44182961)
7. Shiratori Y, Oikawa Y, Yajima J. "Black hole" restenosis after sirolimus-eluting stent implantation. J Invasive Cardiol. 2008;20:E253-255.
8. Oikawa Y, Yajima J, Costa MA, Matsuno S, Akabane M, Funada R, Inaba T, Nakagawa Y, Nakamura M, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Aizawa T. Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: Insights into potential "thromborestenosis" phenomenon. EuroIntervention. 2010;6:380-387.
9. Kurita T, Terashima M, Suzuki T. Serial optical coherence tomography imaging of the "black-hole" phenomenon by intravascular ultrasound following sirolimus-eluting stent implantation. EuroIntervention 2012;7:1481-1482.
10. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv. 2010;75:961-963.
11. Linares Vicente JA, Lukic A, Gonzalo López N, Ruiz Arroyo JR. Atypical "black hole" phenomenon after treatment of sirolimus stent restenosis with paclitaxel-coated balloon. EuroIntervention 2012;7:1479.
12. Templin C, Meyer M, Muller MF, Djonov V, Hlushchuk R, Dimova I, Flueckiger S, Kronen P, Sidler M, Klein K, Nicholls F, Ghadri JR, Weber K, Paunovic D, Corti R, Hoerstrup SP, Luscher TF, Landmesser U. Coronary optical frequency domain imaging (ofdi) for in vivo evaluation of stent healing: Comparison with light and electron microscopy. Eur Heart J. 2010;31: 1792-1801.
13. Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, Ladich ER, Kolodgie FD, Virmani R. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging. 2012;5:71-82.
14. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan Lee C, Park SW, Park SJ. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation. 2011;123:2954-2963.
15. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation. 2007;115:2435-2441. (Pubitemid 46717966)
16. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57:1314-1322.
17. Nakano M, Otsuka F, Virmani R. Letter by Nakano et al regarding article, "Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation". Circulation. 2011;124:e954; author reply e955.